Connect with us


At an event in California, a Brazilian health tech company presented its exclusive technology for blood tests with AI, delivering results within 30 minutes



Newswise — During the AACC – Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, California (USA) from July 23rd to 27th, the Brazilian health tech company Hilab, specializing in clinical analysis tests, participated in the congress alongside ABIMO – Brazilian Association of Medical Devices Industry. The company showcased innovative solutions for the healthcare industry, including two notable launches and the world’s only point-of-care Hemogram device capable of delivering a complete blood count with the assistance of AI and other technologies within 30 minutes.

The Hilab Lens, the smallest point-of-care device for a complete blood count, represents a significant breakthrough in the field of digital microscopy. According to information from ANS- National Health Agency, this test is requested in nearly half of medical orders, as it can identify hundreds of diseases.

The device works by healthcare professionals collecting a blood sample from the fingertip, similar to rapid glucose tests. The extracted sample is placed in a capsule and inserted into the device. The sample information is sent via the Internet of Things to the company’s central laboratory, where the test is verified first by Artificial Intelligence and then by a specialized healthcare professional in hematology. Finally, the test results are sent to the patient’s mobile phone via SMS and email, all within half an hour, while traditional methods take approximately 12 to 48 hours.

Bernardo Almeida, an infectious disease physician, and Chief Medical Officer of Hilab, explains that “the complete blood count is so popular because it evaluates the quantity and quality of the main blood components, supporting the assessment and monitoring of acute infectious conditions, anemia evaluation, as well as assessing overall health. With the test’s ease and speed, medical professionals and patients can benefit from the prompt delivery of results in both routine and emergency cases.”

The efficiency of the device was demonstrated through a pilot operation at the Brazilian hospital Erasto Gaetner, a reference institution for the clinical and surgical treatment of oncology patients in Curitiba (PR). Moreover, its theses were presented and validated in articles published by Nature, one of the most relevant scientific journals in the world. Today, the device is already in use in various healthcare facilities across the country, including occupational medicine companies, clinics, and other locations.

Additionally, Hilab will introduce two new devices at the event: the Hilab Volt and the Hilab Wave. These compact devices will also operate remotely connected via the internet to the health tech’s central laboratory. The Hilab Volt functions based on electrochemistry and reads an electrode that selectively interacts with the sample, generating a useful analytical electrical signal. It will allow the evaluation of indices such as calcium, sodium, potassium, iron, and glucose, among others. The Hilab Wave operates through spectrophotometry, an optical analysis methodology that quantitatively measures the absorption of light by solutions, used for biological and physicochemical investigations. It enables dozens of tests, including phosphorus, magnesium, cholesterol, Vitamin D, and even the incidence of Malaria.

Participating in a scientific and international event of this magnitude reinforces Brazil’s ability to transform the healthcare sector using technology as an ally. For Hilab, as a Brazilian company, this is a particularly special and rewarding moment, marking a positive milestone in their history, indicating that they are on the right path by providing quality and innovative services that can address urgent healthcare access issues worldwide“, says Marcus Figueredo, CEO, and co-founder of Hilab.

Certifications and Recognitions

In 2016, the United Nations, in conjunction with DNV-GL, published a report called “Future of Spaceship Earth,” aiming to showcase companies that were creating technologies capable of achieving the Sustainable Development Goals (SDGs). Hilab was the only company from South America to be chosen and mentioned in the report.

Hilab has also received recognition from the Global Entrepreneurship Competition in Barcelona, being among the 16 most promising ventures in the world. Moreover, it was the winner of the Med Tech Awards, a competition seeking companies with innovative solutions in the healthcare sector, organized by the British Government.

Recently, the company was awarded the MIT Innovative Workplaces seal for its disruptive work in the healthcare sector. The certification from MIT Technology Review, the world’s largest ecosystem for content and innovation, measures the effectiveness of the startup’s innovation-related actions.

About Hilab

Hilab is a 100% Brazilian health tech founded in Curitiba with headquarters in Manaus, developing national devices and technologies for clinical analysis. Its innovative approach allows tests to be conducted using just a few drops of blood. Hilab’s disruptive model differentiates it from traditional laboratories, eliminating the need to transport biological samples. This innovative approach enables the delivery of results in a matter of minutes, providing a faster and more efficient experience for patients. The company employs an advanced technological platform that integrates Artificial Intelligence and the Internet of Things (IoT), enabling the digitization of tests from anywhere in the world, creating a decentralized laboratory.

The company also offers the possibility of conducting tests in loco, without the need to send information remotely. Additionally, Hilab revolutionizes the patient experience by providing less uncomfortable and fingertip-based sample collection. With the use of innovative devices, Hilab simplifies the result delivery process, sending reports signed by healthcare professionals directly to the patient’s mobile phone within 30 minutes.

Source: 2023 AACC Annual Scientific Meeting Press Program


Discover more from Daily News

Subscribe to get the latest posts sent to your email.


Combat the Epidemic of Loneliness by Eating Together



(Family Features) According to the U.S. Surgeon General, Americans face a lack of social connection that poses a significant risk to individual health and longevity. “Loneliness and social isolation increase the risk for premature death by 26% and 29%, respectively. More broadly, lacking social connection can increase the risk for premature death as much as smoking up to 15 cigarettes a day,” per the report.

One way to address this epidemic of loneliness is by sharing a meal with friends and family. Learn five of the specific advantages of family meals identified by the Family Meals Movement and take advantage of these benefits during National Family Meals Month this September by sharing one more meal together each week.

Meals Together Foster Togetherness and Connectedness
Staying connected can be hard when schedules conflict and life gets busy, but shared meals with friends, family or however you define your family can be the glue that holds people together. Studies demonstrate a positive relationship between family meal frequency and measures of family functioning, which is defined as family connectedness, communication, expressiveness and problem-solving. The key is for family members to engage in conversation with one another during mealtimes and take advantage of the one-on-one time without distractions or interruptions from smartphones or other devices.

Meals Together Strengthen Mental Health
An often overlooked benefit of family meals is mental health support. Multiple studies show family meals have long been associated with improving mental health, including reducing symptoms of depression, decreasing violent behavior and lessening thoughts of suicide among youth. Among adolescents, frequent family meals can help mitigate the risks of destructive behaviors by boosting prosocial behaviors and life satisfaction. Data from the FMI Foundation’s “Staying Strong with Family Meals” Barometer shows family meals also help restore a sense of peace, with one-third of survey respondents saying family meals make them feel calm. In short, family meals are a recipe for strengthening emotional well-being among children and adolescents.

Meals Together Improve Nutrition
There is one easy way to help ensure your family is eating fruits and vegetables: a family meal. Research shows family meals improve fruit and vegetable consumption. It also pays to start this trend early, with research finding preschool-aged children who eat frequent family meals are more likely to eat more fruits and vegetables. Overall, researchindicates families who eat together frequently have a better overall healthy diet and lower body mass index.

Meals Together Improve Academic Performance
Helping students’ academic performance begins around the family dinner table. Eating more meals together as a family is associated with improved overall adolescent health, including higher grades. Multiple studies show students whose families eat together frequently perform better academically in areas such as reading and vocabulary. Research also supports a correlation between frequent family meals lowering incidents of risky and harmful behaviors, including drug and alcohol abuse, which may also contribute to school performance.

Meals Together Teach Civility
The family dinner table is a perfect place to show younger generations how to communicate respectfully, according to the Family Meals Barometer summary. In fact, 76% of survey participants agreed family meals are a good opportunity to have and teach respectful interactions while 70% said frequent family meals create a safe environment for families to discuss thornier societal issues. Another 68% affirmed their belief that sitting at a meal together tends to keep conversations more civil.

Learn more about the physical, mental and social benefits of family meals at familymealsmovement.org and follow #familymealsmonth and #familymealsmovement on social media.

Photo courtesy of Shutterstock

FMI Foundation

Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading


A Milestone in Prostate Cancer Research: The Inspiring Success of the RESPOND Study



In a monumental stride toward understanding and combating prostate cancer disparities, the RESPOND study has achieved a landmark victory by recruiting the largest cohort of African American men for prostate cancer research. This comes at a time when the need for such studies is more critical than ever, particularly given the disproportionate impact prostate cancer has on African American men.

Chasing Better Outcomes Amidst Challenges

Statistics reveal daunting disparities: African American men suffer from higher rates of prostate cancer with earlier onset and twice the mortality rate compared to other racial groups. Spearheaded by Dr. Christopher Haiman, a genetic epidemiologist at the University of Southern California (USC), the RESPOND study (Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress) has made remarkable strides in recruiting over 12,600 volunteers, far surpassing its initial goals.

Dr. Christopher Haiman, a genetic epidemiologist at the University of Southern California, is the RESPOND study’s principal investigator.

This success didn’t come easy, especially as the study’s recruitment phase coincided with the dual upheavals of the COVID-19 pandemic and a national reckoning with racial injustice under the Black Lives Matter movement. Nevertheless, the determination and innovative approaches employed by the RESPOND team, including using sophisticated tools like genome-wide genotyping and next-generation sequencing, have not only kept the study on track but also enriched its potential outcomes.

Understanding the Layers: From Genetics to Social Stress

The broad, holistic design of RESPOND allows examination of various factors potentially contributing to the stark disparities seen in prostate cancer outcomes among African American men. Dr. Haiman pointed out the use of geospatial information systems (GIS) to scrutinize the impact of environmental and social stresses on these men. Also, the study is delving into the roles of structural factors such as residential redlining, which historically denied essential services and opportunities based on racial composition of neighborhoods, thus potentially contributing to health disparities.

The Power of Collaboration and Community Engagement

The success of RESPOND owes much to Dr. Ann Hamilton, who co-leads the recruitment efforts drawing from her extensive background in epidemiological studies. Their team’s strategy involved direct engagement with the community, highlighting not only the immediate benefits of participation but also the long-term impacts for future generations. Collaborations with advocacy groups and leveraging community trust were also key to addressing and overcoming the skepticism often associated with participation in medical research among African American communities.

University of Southern California epidemiologist and the RESPOND’s recruitment lead, Dr. Ann Hamilton, with Mr. Freddie Muse, Jr., a men’s health advocate, at a prostate health event in Los Angeles.

The Road Ahead: Data Analysis and Future Research

As RESPond shifts from recruitment to data analysis, the possibilities are promising. Dr. Haiman envisions a series of future studies that could look into treatment types and their effects on survival rates, the use of AI in detecting tumor signatures, and genetic and lifestyle factors contributing to prostate cancer risks among African American men.

Each step forward not only brings us closer to understanding the complex interplay of factors contributing to cancer disparities but also underscores the crucial need for tailored medical research that respects and responds to the unique needs of diverse populations.

A Beacon of Hope

RESPOND stands as a beacon of hope, not just for those battling prostate and other forms of cancers but for the medical research community at large. It exemplifies how perseverance, innovation, and community engagement can come together to pave the way for groundbreaking advancements in health and medicine.

The thorough engagement of over 12,600 African American men in this significant study not only marks a historic achievement but also sets the stage for profound impacts on public health policies and future research methodologies. Through their dedication, the RESPOND team is creating a legacy that will benefit many generations to come, truly embodying the ethos of doing ‘what is needed for future generations’.

A Moment of Reflection

As we move forward, it is crucial to reflect on the lessons learned from the RESPOND study – lessons about resilience, the power of community, and the imperative to continually bridge gaps in healthcare disparities. The journey of RESPOND is far from over, but its impacts will resonate for years to, shaping the contours of minority health research and policy.

The journey towards equitable health outcomes continues, and thanks to initiatives like RESPOND, we are another step closer to a future where health disparities are no longer a barrier to living long, healthy lives.


Support & Further Reading
For further details on the RESPOND study and to support this critical research, please visit RESPOND Study Website. Together, we can make a difference in the lives of millions.

Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading


5 Travel Tips for People with Diabetes




(Family Features) Be it a short weekend trip to an epic destination or a longer trip to a dream spot, 212 million American adults are planning much-deserved vacations, according to The Vacationer’s Summer Travel Survey 2024. However, one thing travelers living with type 1 diabetes can’t leave behind: their diabetes.

This is why many frequent travelers living with type 1 diabetes like Nicky Williams, a full-time student who loves documenting travel on her blog, are always prepared by having a checklist when she travels. This checklist helps those like Williams carefully manage type 1 diabetes and allows them to manage the unexpected.

“I was born with a sense of wanderlust,” Williams said. “However, 14 years ago, my ability to travel was challenged when I was diagnosed with type 1 diabetes. Thanks to my diabetes tech, my love for travel and my passion for trying different foods around the world is as strong as ever. When I travel, I’m less stressed when enjoying new cultures and foods where I might not get the carb count just right. I let my MiniMed 780G system do what it does best and account for the unexpected so I can truly immerse myself in the experience instead of my diabetes.”

If you’re planning a trip this summer and looking for a better way to manage your diabetes, consider these tips:

Talk to Your Health Care Provider
Discuss your current treatment plan and any concerns you have. Talk about adjustments you may need to make, depending on where you’re going, what you’ll be doing and how your diet may be affected. Also be sure to get a current letter stating you have diabetes and any special information regarding your needs that you can provide in the event of an emergency.

Pack Your Supplies
Put your diabetes supplies in a carry-on bag and pack twice as much insulin as you think you’ll need. Consider packing insulin with a gel ice pack, which is less likely to get flagged by luggage scanners. With a solution like the Medtronic Extended infusion set, travelers with diabetes have the option for an extended wear duration of up to seven days, leaving more space for packing other items.

Navigate the Airport
Traveling with a medical device or supplies can be a nerve-wracking experience, especially if flying to your destination. Upon arriving at the security screening, notify security officers of any equipment in your carry-on or attached to your body. While you will not be required to remove an attached device, you may be subject to additional screenings, including a visual inspection, self-pat down and other trace testing of the device and supplies.

Research Pharmacies
Look into where you can access additional supplies if you run low, your luggage gets misplaced, or some other unforeseen event affects your insulin or other supplies. Verify whether the pharmacy accepts your insurance and the types of supplies you might need. You may even want to call ahead to get your information entered in their system so they’re able to help you more efficiently if an urgent need arises. If something happens to your insulin pump, know your options for getting a replacement or loaner while traveling.

Safeguard Your Routine
Mealtimes are consistently cited as one of the most difficult aspects of diabetes management and the change of pace that comes with travel and excursions can disrupt your routine. An automated insulin delivery system can help alleviate that stress for those times when you forget to plan ahead. An option such as the MiniMed 780G system has your back if you occasionally forget or miscalculate a dose. The system’s world-class algorithm measures sugar levels every 5 minutes, assessing if a meal has been eaten and giving automatic corrections and adjustments to insulin. With some of the manual work being taken on by the system, traveling becomes a more seamless experience, allowing you to enjoy your favorite foods, relax and revel in your vacation.

To learn more about managing diabetes on the road, visit medtronicdiabetes.com/TravelTips.

‡ Refers to SmartGuard™ feature. Individual results may vary.
† Taking a bolus 15-20 minutes before a meal helps to keep blood sugar levels under control after eating.

Important safety information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Rx Only. Subcut admin of insulin only. NOT for IV or blood products. Infection/irritation risk possible. Follow directions and replace as indicated. See https://bit.ly/infusionsetsafety

Abbreviated+: Rx Only. Subcut admin of insulin only. NOT for IV or blood products. See https://bit.ly/infusionsetsafety

The content and all information provided is for your informational use only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment in any manner. Responses to a treatment may vary from patient to patient. Always talk with your physician about diagnosis and treatment information and ensure that you understand and carefully follow that information.


Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading